title: Payers consider waiting out budget-busting hepatitis C drug.
authors.forename: John
authors.initials: J
authors.lastname: Carroll
mesh_terms: D000998:Antiviral Agents / Q000191:economics*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D008329:Managed Care Programs / Q000191:economics*; D008484:Medicaid / Q000191:economics; D011057:Politics; D011358:Product Surveillance, Postmarketing; D000069474:Sofosbuvir; D014481:United States; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000191:economics
chemical_list: D000998:Antiviral Agents; D014542:Uridine Monophosphate; D000069474:Sofosbuvir